Vanderbilt University Medical Center
Nashville, Tennessee
Debra L. Friedman, M.D., M.S.
E. Bronson-Ingram Chair in Pediatric Oncology
Professor of Pediatrics
Director, Division of Pediatric Hematology/Oncology
Associate Director for Community Science and Health Outcomes, Vanderbilt-Ingram Cancer Center
Program Co-Leader, Cancer Health Outcomes and Control, Vanderbilt-Ingram Cancer Center
Dr. Friedman is an internationally recognized researcher in cancer care delivery, prevention, control and outcomes and pediatric and adolescent and young adult oncology. She has led Phase III clinical trials in Hodgkin Lymphoma and Retinoblastoma as well as cancer survivorship studies. She has leadership roles in multiple committees in the Children’s Oncology Group and she is an inaugural member of the NCCN Survivorship Panel. She has ongoing research funded by the National Cancer Institute and multiple foundations in cancer care delivery, survivorship and health outcomes.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Friday, May 6, 2022
1:00 PM – 2:25 PM
Friday, May 6, 2022
1:00 PM – 1:05 PM
Friday, May 6, 2022
2:05 PM – 2:25 PM
Friday, May 6, 2022
3:45 PM – 5:15 PM
Friday, May 6, 2022
3:45 PM – 3:50 PM
Friday, May 6, 2022
4:50 PM – 5:10 PM
Friday, May 6, 2022
5:10 PM – 5:15 PM